Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|May 1, 1996
T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failureJ Mehta, R Powles, S Singhal, et al.
Blood|June 14, 2000
Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplantsS Kulkarni, R Powles, J Treleaven, et al.
Experimental Hematology|February 1, 1992
Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM-CSF in vivo and interleukin 4 in vitroB C Millar, J B Bell, J L Millar, et al.
Hematology (Amsterdam, Netherlands)|September 14, 2012
Guidelines on obtaining consent for systemic anti-cancer therapy in adultsJ Treleaven, E Gadd, J Cullis, et al.
British Journal of Cancer|January 1, 1997
Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myelomaN Raje, R Powles, C Horton, et al.
British Journal of Haematology|December 3, 1999
Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging systemB Sirohi, R Powles, J Mehta, et al.
Bone Marrow Transplantation|July 1, 1990
Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemiaD C Talbot, R L Powles, J P Sloane, et al.
Leukemia|February 1, 1995
Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrowF van Rhee, D I Marks, F Lin, et al.
Bone Marrow Transplantation|September 11, 1998
The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescueB C Millar, J L Millar, V Shepherd, et al.
British Journal of Haematology|July 1, 1990
Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myelomaB C Millar, J B Bell, A Montes, et al.
Pageof 19